Idiopathic Pulmonary Fibrosis Susceptibility Identified Via Genomic Markers
Altered expression of 14 genes in adults was associated with idiopathic pulmonary fibrosis susceptibility.
Idiopathic Pulmonary Fibrosis
Chronic Viral Infection May Increase Idiopathic Pulmonary Fibrosis Risk
Persistent or chronic, but not acute, viral infections significantly increase the risk of developing idiopathic pulmonary fibrosis.
Home Oxygen Use Associated With Worsened Physical Function in COPD and IPF
Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.
Sarcoidosis on Associated With Higher Mortality vs COPD, IPF on Transplant List
Patients with sarcoidosis on the lung transplant waiting list had a higher mortality rate than patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.
Plasma Biomarkers of Idiopathic Pulmonary Fibrosis May Predict Survival
Plasma biomarkers of progressive idiopathic pulmonary fibrosis may be markers of progressive pulmonary fibrosis regardless of the type of interstitial lung disease.
Short-Term Effectiveness of Antifibrotics in Idiopathic Pulmonary Fibrosis
Patients taking the antifibrotic medications nintedanib and pirfenidone for idiopathic pulmonary fibrosis had reduced all-cause mortality and hospitalizations for up to 2 years compared with a matched untreated cohort.
Nintedanib Discontinuation in Idiopathic Pulmonary Fibrosis Related to Anorexia
In patients with idiopathic pulmonary fibrosis, anorexia and weight loss during prior treatment with pirfenidone was associated with early termination of subsequent nintedanib therapy.
Support for a Calcium-Based Therapeutic Approach in Pulmonary Fibrosis
Use of a calcium-based therapeutic approach may be helpful for the management of an atypical form of pulmonary fibrosis.
Prognostic Effects of Imaging Ratios in Idiopathic Pulmonary Fibrosis
Investigators sought to determine a potential link between mPA/Ao ratio at diagnosis and clinical characteristics and outcomes in patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis Outcomes Similar With Pneumonia or Acute Exacerbation
Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with pneumonia and patients with an acute IPF exacerbation.
Next post in ATS 2019 Meeting
